Federica Zotta

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

A systematic review of short-term outcomes in patients with anti-factor H associated atypical HUS managed with plasma exchanges versus eculizumab.

A systematic review of short-term outcomes in patients with anti-factor H associated atypical HUS managed with plasma exchanges versus eculizumab.

Journal: Pediatric nephrology (Berlin, Germany)

Published: January 11, 2026

Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosis.

Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosis.

Journal: Frontiers in immunology

Published: November 19, 2025

Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome: an extended follow-up.

Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome: an extended follow-up.

Journal: Frontiers in immunology

Published: November 03, 2025

Comparison of B lymphocyte profile between membranous nephropathy and idiopathic nephrotic syndrome pediatric patients.

Comparison of B lymphocyte profile between membranous nephropathy and idiopathic nephrotic syndrome pediatric patients.

Journal: Pediatric nephrology (Berlin, Germany)

Published: November 21, 2024

A novel flow cytometry panel to identify prognostic markers for steroid-sensitive forms of idiopathic nephrotic syndrome in childhood.

A novel flow cytometry panel to identify prognostic markers for steroid-sensitive forms of idiopathic nephrotic syndrome in childhood.

Journal: Frontiers in immunology

Published: January 31, 2024

Anti-CFH-associated hemolytic uremic syndrome: do we still need plasma exchange?

Anti-CFH-associated hemolytic uremic syndrome: do we still need plasma exchange?

Journal: Pediatric nephrology (Berlin, Germany)

Published: December 08, 2023

A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome.

A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome.

Journal: JCI insight

Published: March 08, 2023

Successful treatment with avacopan (CCX168) in a pediatric patient with C3 glomerulonephritis.

Successful treatment with avacopan (CCX168) in a pediatric patient with C3 glomerulonephritis.

Journal: Pediatric nephrology (Berlin, Germany)

Published: March 07, 2023

Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndrome.

Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndrome.

Journal: Kidney international

Published: December 14, 2022

Severe Bartter syndrome type 1: Prompt postnatal management thanks to antenatal identification of SLC12A1 pathogenic variants.

Severe Bartter syndrome type 1: Prompt postnatal management thanks to antenatal identification of SLC12A1 pathogenic variants.

Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Published: March 17, 2022

Circulating plasmablasts in children with steroid-sensitive nephrotic syndrome.

Circulating plasmablasts in children with steroid-sensitive nephrotic syndrome.

Journal: Pediatric nephrology (Berlin, Germany)

Published: July 09, 2021

Update on the treatment of steroid-sensitive nephrotic syndrome.

Update on the treatment of steroid-sensitive nephrotic syndrome.

Journal: Pediatric nephrology (Berlin, Germany)

Published: December 07, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026